Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/emermed-2024-214354 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effectiveness of Olfactory Training for Cognition and Depressive Symptoms in Middle-Aged and Elderly Adults: A Systematic Review and Meta-Analysis.
Psychogeriatrics
September 2025
Department of Psychiatry, The 4th People's Hospital of Ziyang, Ziyang Psychosis Hospital, Ziyang, China.
Background: Olfactory training (OT) has been proposed as a non-pharmacological intervention to improve cognitive functions and depressive symptomatology, but evidence remains fragmented.
Methods: In this study, we conducted a systematic review and meta-analysis of randomised controlled trials (RCTs) comparing OT versus control in middle-aged and elderly adults. Four databases (PubMed, Cochrane Library, Web of Science, Embase) were systematically searched from database inception through June 2025.
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial.
Lancet
August 2025
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Background: Drug-coated devices are frequently used in coronary and peripheral interventions, but their effect on amputation risk in peripheral artery disease is unclear. We assessed whether drug-coated devices affect the rate of above-ankle amputation in patients with chronic limb-threatening ischaemia undergoing infrainguinal endovascular revascularisation.
Methods: The Swedish Drug-Elution Trial in Peripheral Arterial Disease 1 (SWEDEPAD 1) was a pragmatic, nationwide, multicentre, participant-masked, registry-based, randomised controlled trial at 22 Swedish centres.
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial.
Lancet
August 2025
Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Background: Drug-coated devices are widely used to reduce restenosis after lower limb revascularisation in patients with peripheral artery disease, but their effect on patient-centred outcomes remains unclear. We assessed the effect of paclitaxel-coated devices on clinically important outcomes in patients with intermittent claudication undergoing infrainguinal endovascular revascularisation.
Methods: The Swedish Drug-Elution Trial in Peripheral Arterial Disease 2 (SWEDEPAD 2) was a pragmatic, nationwide, multicentre, participant-masked, registry-based, randomised controlled trial conducted at 22 Swedish vascular centres.
Safety and efficacy of ultrasonic dissection versus electrocautery dissection in laparoscopic cholecystectomy for acute cholecystitis: an updated systematic review and meta-analysis.
Surg Endosc
September 2025
General Surgery Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Background: Laparoscopic cholecystectomy (LC) is the current gold standard for the management of acute cholecystitis, where ultrasonic dissection and electrocautery dissection are the two primary techniques used, however, it remains uncertain which approach is safer and more effective.
Objectives: This systematic review and meta-analysis aimed to compare the clinical outcomes of ultrasonic dissection versus electrocautery dissection in LC for acute cholecystitis, particularly in operative time, hospital stay, blood loss, intraoperative and postoperative complications.
Method: A systematic literature search was conducted in PubMed (MEDLINE), Scopus, Web of Science (WOS), EMBASE, and Cochrane CENTRAL up to January 7, 2025, following PRISMA guidelines.
Clinical efficacy of a novel 3D-printed zirconia single crown: A randomized controlled trial.
J Dent
August 2025
Department of Prosthodontics, Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases of Zhejiang Province, Zhejiang Key Laboratory of Oral Biomedical Research, Hangzhou, Zhejiang, China. Electronic address:
Objectives: This randomized controlled trial (RCT) aims to evaluate the clinical efficacy of Nano Particle Jetting (NPJ)-printed zirconia single crowns compared to Computer-Aided Design/Computer-Aided Manufacturing (CAD/CAM)-milled crowns over a 12-month follow-up period.
Methods: A total of 43 participants with 48 posterior teeth (vital or endodontically treated) were included. Randomization and allocation concealment were conducted using a computer-generated list and sealed envelopes, assigning 24 teeth to each group.